Hypoxia-regulated transgene expression in experimental retinal and choroidal neovascularization
- 30 May 2003
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (12), 1049-1054
- https://doi.org/10.1038/sj.gt.3301945
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapyGene Therapy, 2002
- Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1Gene Therapy, 2002
- In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epitheliumGene Therapy, 2001
- Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularizationJournal of Cellular Physiology, 2001
- Pigment Epithelium-Derived Factor: A Potent Inhibitor of AngiogenesisScience, 1999
- Adeno-Associated Virus Gene Transfer to Mouse RetinaHuman Gene Therapy, 1998
- The Cause-specific Prevalence of Visual Impairment in an Urban PopulationOphthalmology, 1996
- Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNature Medicine, 1995
- Preventative OphthalmologyOphthalmology, 1995
- Laser Photocoagulation of Subfoveal Recurrent Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991